Lonza to Expand Microbial Development Laboratories
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, today announced it has invested in additional microbial development capabilities in Switzerland. The investment will support increased capacity of development services targeting microbial-derived proteins with expanded laboratory space and equipment to be in use by the end of 2021.
November 16, 2021